-
Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals
Source: Pharmafile Published on 2024-04-24
-
GSK’s Jemperli accepted for FDA review for endometrial cancer treatment
Source: Pharmafile Published on 2024-04-24
-
Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia
Source: Pharmafile Published on 2024-04-23
-
FDA approves ImmunityBio’s Anktiva bladder cancer treatment
Source: Pharmafile Published on 2024-04-23
-
EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment
Source: Pharmafile Published on 2024-04-22
-
Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder
Source: Pharmafile Published on 2024-04-22
-
Ardena announces €20m expansion following first GMP approval
Source: Pharmafile Published on 2024-04-19
-
Roche’s Alecensa approved by FDA as lung cancer treatment
Source: Pharmafile Published on 2024-04-19
-
GSK shares results from phase 3 trial for gonorrhoea treatment
Source: Pharmafile Published on 2024-04-18
-
Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity
Source: Pharmafile Published on 2024-04-18
-
Medincell and AbbVie enter agreement for development of next-generation injectables
Source: Pharmafile Published on 2024-04-17
-
Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy
Source: Pharmafile Published on 2024-04-17
-
Novartis shares new data about Fabhalta for IgAN treatment
Source: Pharmafile Published on 2024-04-16
-
GSK’s meningococcal vaccine candidate accepted for FDA review
Source: Pharmafile Published on 2024-04-16
-
Genentech’s Columbi meets primary endpoint in phase 3 trial for lymphoma treatment
Source: Pharmafile Published on 2024-04-15